title: A review of 125 cases to determine the risk of myelodysplasia and leukemia in pediatric neutropenic patients after treatment with recombinant human granulocyte colony-stimulating factor.
authors.forename: S
authors.initials: S
authors.lastname: Imashuku
authors.forename: S
authors.initials: S
authors.lastname: Hibi
authors.forename: F
authors.initials: F
authors.lastname: Nakajima
authors.forename: T
authors.initials: T
authors.lastname: Mitsui
authors.forename: S
authors.initials: S
authors.lastname: Yokoyama
authors.forename: S
authors.initials: S
authors.lastname: Kojima
authors.forename: T
authors.initials: T
authors.lastname: Matsuyama
authors.forename: T
authors.initials: T
authors.lastname: Nakahata
authors.forename: K
authors.initials: K
authors.lastname: Ueda
authors.forename: I
authors.initials: I
authors.lastname: Tsukimoto
mesh_terms: D000328:Adult; D002648:Child; D002675:Child, Preschool; D002897:Chromosomes, Human, Pair 7; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects*; D006801:Humans; D007223:Infant; D007938:Leukemia / Q000209:etiology*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D009006:Monosomy; D009190:Myelodysplastic Syndromes / Q000209:etiology*; D009503:Neutropenia / Q000188:drug therapy*; D011994:Recombinant Proteins; D012189:Retrospective Studies
chemical_list: D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor